BillionToOne, Inc. (BLLN) shares fell 3.66 percent, down $3.04 to $79.92 on Thursday, after the company announced the appointment of Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology, as it expands its Northstar liquid biopsy portfolio.
The stock is currently trading at $79.92, below its previous close of $82.96, after opening at $79.94 on the Nasdaq. Shares traded in a range of $76.28 to $80.43 during the session, with volume at 59,935 shares, below the average daily volume of 280,054.
The company said Chen brings more than 20 years of experience across major academic institutions including University of California, Davis, University of California. BillionToOne's 52-week range is $61.96 to $138.70.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.